Risk Score of Harigai et al for Pneumocystis Pneumonia in a Patient with Rheumatoid Arthritis Treated with Infliximab

Purpose: To determine the risk of pneumocystis pneumonia in a patient with rheumatoid arthritis being treated with infliximab using the score of Harigai et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient with rheumatoid arthritis who is being treated with infliximab?

Yes

Age of the patient

years

Daily dose of prednisolone (or equivalent)

mg per day

Does the patient have underlying lung disease?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total risk score

The risk of the patient developing pneumocystis pneumonia over time is

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Pneumocystis carinii Pneumonia Score of Nichols et al
Laboratory Tests
- Pneumocystis Pneumonia | Model to Predict Mortality in AIDS Patient in ICU
Other Testing
- Pneumocystis Pneumonia | Model to Predict Mortality in AIDS Patient in ICU
Severity, Prognosis, Stage
Complications
- Pneumocystis carinii Pneumonia Score of Nichols et al

Monitoring

Comorbid Conditions
- Pneumocystis jirovecii Pneumonia | Predictors for Mortality in HIV Patient
- Pneumocystis Pneumonia | Model to Predict Mortality in AIDS Patient in ICU

Specialty

Infectious Diseases

Objective

risk factors
severity
prognosis
stage

ICD-10

B59 - Pneumocystosis (J17.3*)
M05 - Seropositive rheumatoid arthritis

Info

Purpose: To determine the risk of pneumocystis pneumonia in a patient with rheumatoid arthritis being treated with infliximab using the score of Harigai et al.

Specialty: Infectious Diseases

Objective: risk factors, severity, prognosis, stage

ICD-10: B59, M05,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path